Clinical Conditions & Care Assessment

← Back to Domain-Specific Families

Abstractions about adverse events, disease and tissue effects, clinical criteria, procedures, medical models, computational patients, and point-of-care information.

10 abstractions in this family — domain-specific abstractions that sit near one another in structural-signature space (k-means over structural-signature embeddings). Each is shown with its short description.

• Adverse Event — Record an unfavorable medical occurrence during treatment without yet attributing it to the treatment, preserving a causally agnostic outer surveillance category from which drug-causal events are separated by explicit causality assessment.
• Atherosclerosis — Characterize the chronic artery-wall disease in which retained apoB-containing lipoproteins, inflammatory and reparative cell responses, extracellular matrix, necrotic material, and often calcification build atheromatous plaques whose remodeling, rupture, erosion, thrombosis, or stenosis can produce ischemic disease.
• Computational human phantom — A digital anatomical model representing human tissues and organs for simulated radiation transport, imaging, biomechanics or other in-silico exposure calculations.
• Exanthem — A widespread eruptive skin rash occurring as part of a systemic illness, commonly infectious but also associated with immune, drug, or inflammatory causes.
• Late effect — A health condition that emerges after the acute phase of a causative disease, injury or treatment, often following an interval without manifestations and sometimes appearing years later.
• Medical model — Represent a presenting health difficulty as signs and symptoms attributable to an individual disease or pathological process, then organize diagnosis, prognosis, and treatment reasoning around that representation.
• Paracentesis — Access a body cavity by percutaneous needle or catheter puncture to obtain fluid for diagnostic assessment or remove an abnormal fluid collection for therapeutic relief under professional clinical governance.
• Point of care medical information summary — Deliver rapidly retrievable, editorially synthesized, periodically updated, evidence-linked clinical topic guidance at the moment of care while exposing scope, currency, provenance, uncertainty, and local applicability limits.
• Ranson criteria — A historical clinical prediction rule combining specified admission and 48-hour findings to stratify severity and mortality risk in acute pancreatitis, with separate gallstone and non-gallstone variants.
• Tissue selectivity — A drug's disproportionate concentration or effect in some tissues rather than others, arising from distribution barriers, transport, metabolism, receptor context, local activation, or biased pharmacodynamic response.